Sinofn Health
Sinofn Health
High-precision nutritional interventions engineered for hospital enteral wards and outpatient metabolic care.
Bucharest, as the economic engine and medical nucleus of Romania, is experiencing a structural paradigm shift in clinical nutrition management. Anchored by premier academic medical facilities such as Spitalul Universitar de Urgență București, Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu”, and Spitalul Clinic de Urgență pentru Copii „Grigore Alexandrescu”, the demand for medical-grade Foods for Special Medical Purposes (FSMP) has expanded far beyond traditional enteral hospital formulas.
The Romanian healthcare landscape faces a dual challenge: an aging demographic profile driving chronic disease prevalence (oncology, sarcopenia, neurodegenerative disorders) and a heightened focus on rare pediatric metabolic conditions such as Phenylketonuria (PKU). However, local manufacturing in the CEE (Central and Eastern Europe) region remains fragmented, creating acute bottlenecks in cost control, specialized amino acid formulation scaling, and compliance with rigid EU Commission Delegated Regulation (EU) 2016/128.
Bridging the gap between European regulatory standards and high-volume smart production infrastructure.
Utilizing computer-controlled micro-dosing systems and vacuum low-temperature continuous mixing technology. Ensures homogenous distribution of micronutrients without thermal degradation of bioactive peptides.
Blockchain-enabled batch serialization from raw amino acid synthesis to final pouch packaging. Provides complete transparency required for European medical device and FSMP audits.
Multi-ton operational capacity drastically lowers per-unit production costs for Bucharest pharmaceutical distributors while maintaining compliance with EU GMP Class 100,000 cleanroom standards.
| Evaluation Dimension | Local CEE Boutique Suppliers | SINOFN Smart OEM/ODM Infrastructure |
|---|---|---|
| Production Scalability | Limited batch capacity, vulnerable to raw material shortages | Annual capacity 500M+ units across 10+ dedicated automated lines |
| R&D & Formulation Depth | Standard off-the-shelf premixes | CAS Partnership R&D Team with 25+ patents & proprietary enzymatic peptide tech |
| Regulatory Compliance | EU local focus only | ISO 22000, HACCP, FSSC 22000, HALAL, and EU Delegated Regulation 2016/128 compliant |
| Cost Optimization | High overhead and processing costs | 40-60% unit cost reduction via vertical supply chain integration |
| Customization Speed | 12-18 months formulation cycle | Rapid pilot prototyping with 60-day turnarounds for bespoke clinical formulas |
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences (CAS). Operating from Shanghai as our global commercial and trading hub, we provide premium, science-driven contract manufacturing services to partners across Bucharest, Europe, and worldwide.
We combine cutting-edge pharmaceutical formulation expertise with large-scale industrial manufacturing, empowering brands and medical distributors to launch validated clinical nutrition products efficiently.
"During my clinical work, I witnessed the lifelong struggles of PKU (Phenylketonuria) children – where specialized diets were financially out of reach. Driven to bridge this gap, I founded SINOFN in 2012 to develop affordable, science-backed PKU foods."
Profit with Purpose: Dedicates a portion of revenues to PKU accessibility initiatives globally while fueling transformation from PKU specialization into complete FSMP and clinical nutrition portfolios.
Through strategic cooperation with top research institutions and Peking University Medical School, SINOFN bridges nutritional science with industrial scale.
Ph.D., Peking University Medical School. 15+ years of specialized research in metabolic disorder formulations and therapeutic amino acid ratios.
Associate Researcher, Chinese Academy of Sciences (CAS) Postdoc. Specialist in bioactive compound delivery systems and micro-encapsulation tech.
Senior Scientist (Netherlands). Chief Engineer specializing in EU regulatory compliance, FSMP industrialization, and oral peptide delivery tech.
Rigorous quality validation frameworks engineered to fulfill European Commission medical standards.
10+ dedicated automated lines (softgels, gummies, powders, ready-to-drink liquids). ISO 22000, HACCP, FSSC 22000 certified with an annual capacity exceeding 500M+ units.
Explore Specifications ➔
In-house HPLC/GC-MS contaminant screening, heavy metal detection, microbiological safety testing, accelerated stability validation, and nutrient dissolution profiling.
Explore Specifications ➔
Pilot-scale prototyping for tablets, hard capsules, liquid sachets, and specialized nutrient powders. Comprehensive bioavailability and taste-masking optimization studies.
Explore Specifications ➔
Automated raw material storage to end-stage production and packing. Features integrated blockchain batch tracking and BRCGS-certified climate-controlled warehousing.
Explore Specifications ➔SINOFN prioritizes intellectual property and international standard compliance, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. Certified with ISO9001, ISO22000, HACCP, and HALAL.
Tailoring OEM/ODM product matrixes to specific pathology demands across Romanian medical institutions.
Providing customized amino acid mixtures completely devoid of Phenylalanine, enriched with L-Carnitine, Taurine, and essential micro-nutrients. Tailored specifically for infant, pediatric, and adult PKU patients under Romanian National Health Program directives.
High-density energy and protein total nutrient admixtures formulated with hydrolysed whey protein isolates, BCAA peptides, and omega-3 fatty acids to combat muscle wasting (cachexia) during chemotherapy in Bucharest hospital wards.
Specialized oral nutritional formulas integrating GABA, Jujube seed extract, and bio-available minerals to support cognitive balance, sleep architecture, and metabolic recovery in post-acute care nursing homes.
Plant-based Cyclic Adenosine Monophosphate (cAMP) and ultra-high concentrated cAMP Jujube extracts engineered for advanced nutraceutical formulations requiring targeted cellular energy signaling modulation.
Explore our ready-to-scale clinical nutrition and nutraceutical formulations engineered for immediate batch manufacturing.
Addressing technical, regulatory, and logistics queries for Romanian healthcare buyers and distributors.
Partner with SINOFN for high-precision FSMP contract manufacturing, CAS-backed R&D, and cost-efficient global logistics.
Send Inquiry Now ➔
